z-logo
open-access-imgOpen Access
Assessment of the relationship between the molecular properties of calcium channel blockers and plasma protein binding data
Author(s) -
Jadranka Odović,
Jovana Trbojevic,
Jasna TrbojevićStanković,
Dejan Nešić,
Ratomir Jelić
Publication year - 2016
Publication title -
archives of biological sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.217
H-Index - 25
eISSN - 1821-4339
pISSN - 0354-4664
DOI - 10.2298/abs160609094o
Subject(s) - lipophilicity , felodipine , diltiazem , chemistry , nisoldipine , nimodipine , nifedipine , nicardipine , verapamil , linear regression , calcium channel , isradipine , molecular descriptor , pharmacology , quantitative structure–activity relationship , dihydropyridine , calcium , stereochemistry , organic chemistry , mathematics , medicine , statistics , blood pressure
In this study we investigated the relationship between the calcium channel blockers (CCBs), amlodipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, nisoldipine, verapamil and diltiazem, and their calculated molecular descriptors: polar surface area (PSA), molecular weight (Mw), volume value (Vol), aqueous solubility data (logS), lipophilicity (logP), acidity (pKa values) and plasma protein binding (PPB) data, obtained from relevant literature. The relationships between the computed molecular properties of selected CCBs and their PPB data were investigated by simple linear regression analysis that revealed very low correlations (R2<0.35). When multiple linear regression (MLR) analysis was applied to investigate reliable correlations between the CCBs’ calculated molecular descriptors and PPB data, the best correlations were found for the relationships between CCBs, and PPB data and lipophilicity, and with application of the molecular descriptor (Mw, Vol, or pKa) data as additional independent variables (R2=0.623; R2=0.741; R2=0.657, respectively), with an acceptable probability value (P<0.05), confirming that lipophilicity, together with other molecular properties, are essential for the drugs’ PPB. We conclude that this could be considered as an additional in vitro approach for modeling CCBs. [Projekat Ministarstva nauke Republike Srbije, br. TR34031

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom